Literature DB >> 26825328

Electromagnetic interference in implantable cardioverter defibrillators: present but rare.

Gesa von Olshausen1, Ina-Christine Rondak2, Carsten Lennerz3, Verena Semmler3, Christian Grebmer3, Tilko Reents3, Sonia Ammar-Busch3, Alessandra Buiatti3, Felix Bourier3, Isabel Deisenhofer3, Christof Kolb3.   

Abstract

PURPOSE: Electromagnetic interference (EMI) with implantable cardioverter defibrillators (ICDs) can cause oversensing and subsequently inappropriate ICD therapies. We retrospectively investigated the current incidence and clinical relevance of oversensing related EMI in a large cohort of ICD patients.
METHODS: From January 2005 to April 2013, all ICD interrogations performed at our institution were analyzed for the occurrence of oversensing related EMI. EMI episodes were classified as clinically significant, potentially significant or of minor significance. To identify risk factors for EMI, we also analyzed different lead models in our cohort (integrated vs true bipolar leads).
RESULTS: Data of 2940 ICD patients (mean age 63 ± 16 years, 2322 male patients, 7772 patient-years) were retrospectively analyzed for the occurrence of EMI. During the observation period, a total of 145 (hospital environment n = 97, non-hospital environment n = 48) episodes occurred and resulted in an overall EMI incidence, i.e. event rate, of 1.87 % per patient per year. Focusing on clinically significant or potentially significant episodes, the EMI incidence was 0.27 % per patient per year. Cox proportional hazards regression analysis did not reveal a statistically significant higher hazard of oversensing for patients with integrated bipolar leads compared to patients with true bipolar leads (HR = 2.21; 95 % CI 0.90-5.39; p = 0.083).
CONCLUSIONS: Our data demonstrate that EMI continues to occur in everyday life. Patients should be well informed about the potential sources and risks of EMI but they need not be overly concerned since the risk of EMI-especially in a non-hospital environment-is low.

Entities:  

Keywords:  Electromagnetic interference (EMI); ICD therapy; Implantable cardioverter defibrillator (ICD); Ventricular oversensing

Mesh:

Year:  2016        PMID: 26825328     DOI: 10.1007/s00392-016-0965-1

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  36 in total

1.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

Authors:  Michael R Bristow; Leslie A Saxon; John Boehmer; Steven Krueger; David A Kass; Teresa De Marco; Peter Carson; Lorenzo DiCarlo; David DeMets; Bill G White; Dale W DeVries; Arthur M Feldman
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

Review 2.  Electromagnetic interference and implanted cardiac devices: the nonmedical environment (part I).

Authors:  Juna Misiri; Fred Kusumoto; Nora Goldschlager
Journal:  Clin Cardiol       Date:  2012-04-26       Impact factor: 2.882

3.  Interference between active implanted medical devices and electromagnetic field emitting devices is rare but real: results of an incidence study in a population of physicians in France.

Authors:  Martine Hours; Inès Khati; Joel Hamelin
Journal:  Pacing Clin Electrophysiol       Date:  2013-09-13       Impact factor: 1.976

4.  Shock whilst gardening--implantable defibrillators & lawn mowers.

Authors:  G Von Olshausen; C Lennerz; C Grebmer; H Pavaci; C Kolb
Journal:  QJM       Date:  2013-09-09

Review 5.  Troubleshooting implanted cardioverter defibrillator sensing problems I.

Authors:  Charles D Swerdlow; Samuel J Asirvatham; Kenneth A Ellenbogen; Paul A Friedman
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-12

Review 6.  The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS).

Authors:  George H Crossley; Jeanne E Poole; Marc A Rozner; Samuel J Asirvatham; Alan Cheng; Mina K Chung; T Bruce Ferguson; John D Gallagher; Michael R Gold; Robert H Hoyt; Samuel Irefin; Fred M Kusumoto; Liza Prudente Moorman; Annemarie Thompson
Journal:  Heart Rhythm       Date:  2011-07       Impact factor: 6.343

7.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

Authors:  A J Moss; W J Hall; D S Cannom; J P Daubert; S L Higgins; H Klein; J H Levine; S Saksena; A L Waldo; D Wilber; M W Brown; M Heo
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

8.  Interference with cardiac pacemakers by cellular telephones.

Authors:  D L Hayes; P J Wang; D W Reynolds; M Estes; J L Griffith; R A Steffens; G L Carlo; G K Findlay; C M Johnson
Journal:  N Engl J Med       Date:  1997-05-22       Impact factor: 91.245

9.  Ventricular oversensing in 518 patients with implanted cardiac defibrillators: incidence, complications, and solutions.

Authors:  T Rauwolf; M Guenther; N Hass; A Schnabel; M Bock; M U Braun; R H Strasser
Journal:  Europace       Date:  2007-09-26       Impact factor: 5.214

10.  Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.

Authors:  Christof Kolb; Marcio Sturmer; Peter Sick; Sebastian Reif; Jean Marc Davy; Giulio Molon; Jörg Otto Schwab; Giuseppe Mantovani; Dan Dan; Carsten Lennerz; Alberto Borri-Brunetto; Dominique Babuty
Journal:  JACC Heart Fail       Date:  2014-10-01       Impact factor: 12.035

View more
  4 in total

1.  Incidence of magnet mode in patients with implantable cardioverter defibrillators.

Authors:  Gesa von Olshausen; Johanna Schorr; Christian Grebmer; Severin Weigand; Patrick Blažek; Amir Brkic; Lena Friedrich; Verena Semmler; Christof Kolb; Carsten Lennerz
Journal:  J Interv Card Electrophysiol       Date:  2019-10-16       Impact factor: 1.900

2.  Perioperative Sensor and Algorithm Programming in Patients with Implanted ICDs and Pacemakers for Cardiac Resynchronization Therapy.

Authors:  Alexander Niedermeier; Laura Vitali-Serdoz; Theodor Fischlein; Wolfgang Kirste; Veronica Buia; Janusch Walaschek; Harald Rittger; Dirk Bastian
Journal:  Sensors (Basel)       Date:  2021-12-14       Impact factor: 3.576

Review 3.  Perioperative Management of Patients with Cardiac Implantable Electronic Devices and Utility of Magnet Application.

Authors:  Tardu Özkartal; Andrea Demarchi; Maria Luce Caputo; Enrico Baldi; Giulio Conte; Angelo Auricchio
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

4.  Electromagnetic interference in cardiac electronic implants caused by novel electrical appliances emitting electromagnetic fields in the intermediate frequency range: a systematic review.

Authors:  Sarah Driessen; Andreas Napp; Kristina Schmiedchen; Thomas Kraus; Dominik Stunder
Journal:  Europace       Date:  2019-02-01       Impact factor: 5.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.